Irina Haivas, the surgeon converted into venture capital who joined the London-based venture capital firm Atomico at the end of 2018 and has already led several investments on behalf of the company, has been promoted to partner.
His Atomico investments to date include: Healx, the Cambridge-based startup in the United Kingdom that uses AI to help discover new treatments for rare diseases (and is clearly a big bet for Atomico); Accurx, the courier service for medical surgeries (he gave me the news of the Serie A directed by Atomico in February 2019); and Kheiron Medical Technologies, a machine learning startup that helps support radiologists.
What is particularly interesting about that list is that Haivas was able to lead those investments as a director, dispelling the myth that it is necessary to be a partner to obtain and lead investments, at least, that is not the case in Atomico. In that sense, it is the same as always, and being promoted is the recognition of his work to date and clearly a sign that the VC does not want to lose it.
To that end, Haivas will continue to invest in “cutting-edge technologies” and deep-tech business companies, but in its new role it will also direct Atomico’s investments in the area of health and biology 2.0, the term that the VC uses to describe the companies that apply engineering and computer principles and tools for biological problems. (You can read his thoughts on Biology 2.0 in a blog post).
Originally as a practicing surgeon, Haivas joined Atomico after working at GHO Capital Partners, a specialized growth investor specialized in health care, and before that, at Bain & Co in Europe and the US. UU. He also has operational experience at Medtronic, a large medical engineering company. Prior to this, she trained as a doctor and was a surgical fellow at Harvard Medical School before completing a Master’s Degree in International Health Policy at the London School of Economics.
Meanwhile, Haivas is the latest in a series of Atomico promotions in recent years. In September 2017, Tom Wehmeier, Head of Research at the firm, became a partner. Then, in November 2018, Sophia Bendz, former global marketing director of Spotify, was promoted to partner. And in March 2019, three new (non-investment) partners were added to the list: Bryce Keane (communications), Alison Smith (chief of staff) and Camilla Richards (investor relations).
There have also been exits. More recently, longtime partner Mattias Ljungman left to raise his own seed fund. Before that, Carolina Brochado jumped off the ship to join the SoftBank Vision Fund in London, and Teddie Wardi went to America to join Insight.